March 28, 2025 | #MedscapeEducation #AICardiology
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and outcomes.

One of the key areas where AI is making a significant impact is in the early detection of cardiovascular diseases (CVD). Traditional methods often fail to diagnose CVD before symptoms appear, leading to delayed treatment and poorer outcomes. AI, however, can analyse vast amounts of data from electrocardiograms (ECGs) and other diagnostic tools to identify early signs of heart disease that might be missed by human eyes, which improves diagnostic accuracy and patient outcomes.1
AI also plays a crucial role in personalising treatment plans. By analysing patient data, AI can help doctors tailor treatments to individual needs, ensuring that each patient receives the most effective therapy. This personalised approach is particularly beneficial in managing complex conditions like heart failure, where treatment needs to be adjusted frequently based on the patient’s response.
The use of wearable and portable devices is another exciting development in AI cardiology. These devices, such as smartwatches and portable ECG monitors, enable continuous monitoring of heart health, providing real-time data to both patients and healthcare providers. This continuous monitoring can lead to early intervention and better management of chronic conditions, ultimately reducing hospitalisations and improving quality of life.2
Despite these advancements, there are still significant challenges to overcome when it comes to getting healthcare professionals confident about realising the full potential of these AI-powered technologies and tools. Healthcare professionals already face an exponential rise in medical information which is doubling at least every 73 days.3 Furthermore, the integration of AI into healthcare systems requires robust data privacy measures and regulatory oversight to ensure patient safety and data security.4
AI is poised to transform cardiology by enhancing early disease detection, personalising treatment and improving overall care quality. As technology continues to evolve, the potential for AI to improve outcomes for patients with cardiovascular disorders is immense; however, ongoing education is needed in its widespread adoption to ensure it is being utilised to its full capabilities. The future of cardiology is bright, with AI leading the way towards more efficient, accurate and personalised care.
If you want to learn more about how Medscape Education is improving outcomes in cardiology through education, contact Ellen Jenner
[1] Attia, Z.I., et al. (2019). ‘An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction’, The Lancet, 394(10201), pp. 861–867. doi: 10.1016/S0140-6736(19)31721-07.
[2] Khunte, A., et al. (2023). ‘Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices’, NPJ Digital Medicine, 6(1), p. 124. doi: 10.1038/s41746-023-00869-w.
[3] Koenig, H.G. (2012) ‘Religion, spirituality, and health: The research and clinical implications’, International Scholarly Research Notices, 2012, pp. 1–33. doi: 10.5402/2012/278730.
[4] Chustecki M. Interact J Med Res. 2024;13:e53616; Davenport T, et al. Future Healthc J. 2019;6:94-98; Khera R, et al. J Am Coll Cardiol. 2024;84:97-114; Khera R, et al. JAMA. 2023;330:2255-2257.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Medscape team has bid farewell to the beautiful city of Milano, Italy and our European nephrology colleagues. The team was thrilled to meet up with so many ground-breaking clinicians,...
Shari Dermer, PhD of Medscape Education, hosted Michael Betel, Founder and President of Fatty Liver Alliance, in an engaging conversation around the importance of NASH awareness, diagnosis, and prognosis. Listen...
The Medscape Oncology team has made their way back from Frankfurt, Germany after another successful EHA 2023 conference. While at the event, the team interacted with conference attendees at the...
ASCO 2023 was a huge success for Medscape Oncology with connections made with members and conference attendees during the event at the Medscape Oncology booth on the exhibit floor and...
This week Medscape Oncology announced an exciting collaboration with ASCO® which you read on the Cision PR news wire here or below:The American Society of Clinical Oncology (ASCO®), a leader at...
Medscape is headed back to Milano, Italy for the 2023 European Renal Association conference, #ERA23.This year, the team is elevating the outcomes of recent nephrology education programs to share the story...
The Medscape Education team will be on site at the 2023 EHA conference in Frankfurt, Germany to share the outcomes of recent hematology education programs and to advance the discussion on...
During the 2023 annual meeting of ACOG, Medscape highlighted the outcomes of CME/CE programs focused on improving clinicians knowledge and achieving better outcomes for patients. The outcomes were shared through...
Recently, DDW 2023 took place in Chicago, IL, and Medscape was on-site with patient advocacy organizations to help educate clinicians on health equity in gastroenterology.Medscape was joined during the conference...
During the Alliance For Continuing Education in the Health Professions Industry Summit Medscape Education was awarded a Best in Class designation for its use of Real-World Outcomes to measure the impact of...
